Agenus, Inc. (AGEN)
8.245
+0.16
(+1.92%)
USD |
NASDAQ |
Sep 03, 16:00
8.245
0.00 (0.00%)
After-Hours: 20:00
Agenus Price : 8.245 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 8.07 | 8.28 | 7.685 | 8.09 | 663996.0 |
| Sep 01, 2026 | 7.56 | 8.00 | 7.54 | 7.99 | 676565.0 |
| Aug 31, 2026 | 7.68 | 7.76 | 7.50 | 7.61 | 721032.0 |
| Aug 28, 2026 | 7.98 | 8.07 | 7.614 | 7.66 | 741162.0 |
| Aug 27, 2026 | 8.28 | 8.52 | 7.78 | 7.81 | 783674.0 |
| Aug 26, 2026 | 8.30 | 8.40 | 8.03 | 8.25 | 779942.0 |
| Aug 25, 2026 | 7.80 | 8.50 | 7.80 | 8.36 | 1.182M |
| Aug 24, 2026 | 8.07 | 8.07 | 7.60 | 7.67 | 775158.0 |
| Aug 21, 2026 | 7.58 | 8.35 | 7.577 | 8.09 | 1.518M |
| Aug 20, 2026 | 8.22 | 8.25 | 7.31 | 7.49 | 1.576M |
| Aug 19, 2026 | 7.66 | 8.735 | 7.620 | 8.26 | 2.290M |
| Aug 18, 2026 | 7.13 | 7.645 | 7.08 | 7.53 | 967559.0 |
| Aug 17, 2026 | 7.30 | 7.305 | 6.960 | 7.15 | 831412.0 |
| Aug 14, 2026 | 6.93 | 7.46 | 6.83 | 7.32 | 1.252M |
| Aug 13, 2026 | 6.85 | 7.03 | 6.71 | 7.00 | 624952.0 |
| Aug 12, 2026 | 6.91 | 7.20 | 6.83 | 6.90 | 1.154M |
| Aug 11, 2026 | 6.84 | 6.895 | 6.42 | 6.83 | 1.374M |
| Aug 10, 2026 | 6.83 | 7.09 | 6.36 | 7.00 | 1.923M |
| Aug 07, 2026 | 7.52 | 7.550 | 6.92 | 6.96 | 1.191M |
| Aug 06, 2026 | 7.67 | 8.85 | 7.323 | 7.49 | 2.455M |
| Aug 05, 2026 | 8.35 | 8.524 | 7.690 | 7.78 | 1.457M |
| Aug 04, 2026 | 7.85 | 8.38 | 7.75 | 8.30 | 2.017M |
| Aug 03, 2026 | 7.65 | 8.09 | 7.50 | 7.82 | 1.654M |
| Jul 31, 2026 | 7.79 | 7.98 | 7.32 | 7.50 | 1.574M |
| Jul 30, 2026 | 6.77 | 7.99 | 6.51 | 7.91 | 3.003M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novavax, Inc. | 10.34 |
| Amgen, Inc. | 443.99 |
| Anika Therapeutics, Inc. | 21.01 |
| BioCryst Pharmaceuticals, Inc. | 10.10 |
| Imunon, Inc. | 1.555 |
Price Related Metrics
| PE Ratio | 3.110 |
| PS Ratio | 2.296 |
| Earnings Yield | 32.15% |
| Market Cap | 351.37M |
| Operating PE Ratio | 8.491 |
| Normalized PE Ratio | 8.260 |